UCI develops low-cost, accurate COVID-19 antibody detection platform

UCI develops low-cost, accurate COVID-19 antibody detection platform
The TinyArray imager has the antibody testing accuracy of machines 100 times more expensive and can be deployed in low-resource areas around the world. Timothy Abram

A robust, low-cost imaging platform utilizing lab-on-a-chip technology created by University of California, Irvine scientists may be available for rapid coronavirus diagnostic and antibody testing throughout the nation by the end of the year.

The UCI system can go a long way toward the deployment of a vaccine for COVID-19 and toward reopening the economy, as both require widespread testing for the virus and its antibodies. So far, antibody testing in the U.S. has been too inaccurate or expensive to reach the necessary numbers.

But UCI investigators Weian Zhao, Per Niklas Hedde, Enrico Gratton and Philip Felgner believe that their new technology can help accelerate the testing process quickly and affordably. Their discovery appears in the journal Lab on a Chip, which is published by the Royal Society of Chemistry.

“We need to test millions of people a day, and we’re very far from that,” said Hedde, a project scientist in pharmaceutical sciences and the study’s lead author. “This accurate testing platform enables public health officers to implement individualized mitigation strategies that are needed to safely reopen the country and economy.”

Read the full press release here: https://bit.ly/2Dx9sIF

-Nicole Feldman/UCI

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

News

Single-Minded Sibling

They’re known around UCI as “the three siblings” – two sisters and a brother who not only share an on-campus apartment, but also work as

0 Shares
Share
Tweet
Share